Phosphatidylserine-selective targeting and anticancer effects of SapC-DOPS nanovesicles on brain tumorsVictor Blanco(University of Cincinnati Medical Center), Xiaoyang Qi(University of Cincinnati Medical Center)OncotargetJuly 14, 201410.18632/oncotarget.2214Cited by 54SaveCiteExport RISWatch citationsRelated PapersTargeting and Cytotoxicity of SapC-DOPS Nanovesicles in Pancreatic Cancer|PLoS ONE|2013|41TLR2-Bound Cancer-Secreted Hsp70 Induces MerTK-Mediated Immunosuppression and Tumorigenesis in Solid Tumors|Cancers|2025|9Electric Fields Regulate In Vitro Surface Phosphatidylserine Exposure of Cancer Cells via a Calcium-Dependent Pathway|Biomedicines|2023|5Targeting Hsp70 Immunosuppressive Signaling Axis with Lipid Nanovesicles: A Novel Approach to Treat Pancreatic Cancer|Cancers|2025|0